Does Pathological Complete Response after Neoadjuvant Therapy Influence Postoperative Morbidity in Rectal Cancer after Transanal Total Mesorectal Excision?
Anastomotic leak
Neoadjuvant therapy
Pathological complete response
Postoperative outcomes
Transanal total mesorectal excision
Journal
Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
accepted:
04
04
2022
medline:
18
8
2023
pubmed:
7
5
2022
entrez:
6
5
2022
Statut:
ppublish
Résumé
It is still unclear if pathological complete response (pCR) after neoadjuvant chemoradiotherapy (CRT) in patients treated for rectal cancer causes worse postoperative outcomes, especially after transanal total mesorectal excision (TaTME). Worse postoperative outcomes might be an argument for an organ preserving watch and wait strategy in fragile patients and patients with comorbidities. The aim of this study is to evaluate whether patients treated for rectal cancer who had pCR to neoadjuvant therapy develop worse postoperative outcomes after TaTME than patients without complete response. Comparative retrospective analysis (with nearest neighbor matching algorithm) of postoperative outcomes in two groups of patients, with pCR, n = 15 and without pCR (non-pCR), n = 57. All patients were operated on only by one surgical approach, TaTME, for middle and distal rectal tumors. All procedures were performed by one surgical team between 2014 and 2020 at the University Hospital Brno in Czech Republic. Overall morbidity was comparable between the groups (pCR group - 53.8% vs. non-pCR - 38.6%, p = 0.381). Anastomotic leak (AL) was observed in 33.3% of patients with pCR and in 17.5% of patients in the non-pCR group without statistical significance (p = 0.281). In conclusion, pathological complete response after neoadjuvant therapy does not appear to affect postoperative morbidity in rectal cancer after TaTME. Therefore, in patients with complete response who are not adherent to W&W surveillance, surgical resection can be perform without increased postoperative complications.
Identifiants
pubmed: 35524090
doi: 10.1007/s12029-022-00826-y
pii: 10.1007/s12029-022-00826-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
528-535Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo L-J, Calvo FA, García-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin M, Pucciarelli S, Small W, Suárez J, Theodoropoulos G, Biondo S, Beets-Tan RG, Beets GL. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11:835–44. https://doi.org/10.1016/S1470-2045(10)70172-82 .
doi: 10.1016/S1470-2045(10)70172-82
pubmed: 20692872
Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99:918–28. https://doi.org/10.1002/bjs.8702 .
doi: 10.1002/bjs.8702
pubmed: 22362002
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol. 2010;17:1471–1474. https://doi.org/10.1245/s10434-010-0985-4 .
Pox C, Aretz S, Bischoff S, et al. S3-Leitlinie Kolorektales Karzinom Version 1.0 - Juni 2013 AWMF-Registernummer: 021/007OL. Z Für Gastroenterol. 2013;51:753–854. https://doi.org/10.1055/s-0033-1350264 .
doi: 10.1055/s-0033-1350264
National Comprehensive Cancer Network. Rectal Cancer (version 1.2021). 2021. https://www.nccn.org/professionals/physician_gls/default.aspx#rectal . Accessed 7 September 2021.
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae .
Rahbari NN, Weitz J, Hohenberger W, et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010;147:339–51. https://doi.org/10.1016/j.surg.2009.10.012 .
doi: 10.1016/j.surg.2009.10.012
pubmed: 20004450
Campa-Thompson M, Weir R, Calcetera N, Quirke P, Carmack S. Pathologic processing of the total mesorectal excision. Clin Colon Rectal Surg. 2015;28:043–52. https://doi.org/10.1055/s-0035-1545069 .
doi: 10.1055/s-0035-1545069
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12:19–23. https://doi.org/10.1007/s003840050072 .
doi: 10.1007/s003840050072
pubmed: 9112145
van der Sluis FJ, Couwenberg AM, de Bock GH, Intven MPW, Reerink O, van Leeuwen BL, van Westreenen HL. Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer. Br J Surg. 2020;107:131–9. https://doi.org/10.1002/bjs.11324 .
doi: 10.1002/bjs.11324
pubmed: 31625143
Landi F, Espín E, Rodrigues V, Vallribera F, Martinez A, Charpy C, Brunetti F, Azoulay D, de’Angelis N,. Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy. Int J Colorectal Dis. 2017;32:255–64. https://doi.org/10.1007/s00384-016-2685-4 .
doi: 10.1007/s00384-016-2685-4
pubmed: 27757541
Duldulao MP, Lee W, Le M, Wiatrek R, Nelson RA, Chen Z, Li W, Kim J, Garcia-Aguilar J. Surgical complications and pathologic complete response after neoadjuvant chemoradiation in locally advanced rectal cancer. Am Surg. 2011;77:1281–5.
doi: 10.1177/000313481107701001
pubmed: 22127070
Maggiori L, Bretagnol F, Aslam MI, Guedj N, Zappa M, Ferron M, Panis Y. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision? Surgery. 2014;155:468–75. https://doi.org/10.1016/j.surg.2013.10.020 .
doi: 10.1016/j.surg.2013.10.020
pubmed: 24439750
Horisberger K, Hofheinz RD, Palma P, Volkert AK, Rothenhoefer S, Wenz F, Hochhaus A, Post S, Willeke F. Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? Int J Colorectal Dis. 2008;23:257–64. https://doi.org/10.1007/s00384-007-0408-6 .
doi: 10.1007/s00384-007-0408-6
pubmed: 18071720
Wolf JH, Hung YC, Cox S, Aghedo B, Mavanur A, Svoboda S, D’Adamo CR. Pathologic complete response is associated with decreased morbidity following rectal cancer resection. Am J Surg. 2021;222(2):390–4. https://doi.org/10.1016/j.amjsurg.2020.11.050 (Epub 2020 Nov 28 PMID: 33261851).
doi: 10.1016/j.amjsurg.2020.11.050
pubmed: 33261851
Yang J, Wang W, Luo Y, Huang S, Fu Z. Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2022;26:163–74. https://doi.org/10.1007/s10151-021-02564-y .
doi: 10.1007/s10151-021-02564-y
pubmed: 35048217
Zaborowski AM, Stakelum A, Winter DC. Anastomotic leak risk in complete responders to neoadjuvant therapy for rectal cancer: a systematic review. Int J Colorectal Dis. 2021;36:671–6. https://doi.org/10.1007/s00384-021-03833-w .
doi: 10.1007/s00384-021-03833-w
pubmed: 33427960
Kim SH, Chang HJ, Kim DY, Park JW, Baek JY, Kim SY, Park SC, Oh JH, Yu A, Nam B-H. What is the ideal tumor regression grading system in rectal cancer patients after preoperative chemoradiotherapy? Cancer Res Treat. 2016;48:998–1009. https://doi.org/10.4143/crt.2015.254 .
doi: 10.4143/crt.2015.254
pubmed: 26511803
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP, International TaTME Registry Collaborative. Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the International TaTME Registry. Ann Surg. 2019;269:700–11. https://doi.org/10.1097/SLA.0000000000002653 .
doi: 10.1097/SLA.0000000000002653
Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva e Sousa AH, Campos FG, Kiss DR, Gama-Rodrigues J,. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Trans Meet Am Surg Assoc. 2004;122:309–16. https://doi.org/10.1097/01.sla.0000141194.27992.32 .
doi: 10.1097/01.sla.0000141194.27992.32